Insys Shareholders Want Stay Lifted In Fentanyl Chancery Suit
A class of shareholders suing pharmaceutical maker Insys Therapeutics Inc. and its directors over an alleged scheme to market a powerful opioid for off-label uses asked the Delaware Chancery Court to...To view the full article, register now.
Already a subscriber? Click here to view full article